130 related articles for article (PubMed ID: 38373111)
1. Retrospective analysis of cytology and high-risk HPV testing in 1067 endocervical adenocarcinomas and precursor lesions.
Ye L; Gan M; Yao Y; Lu B
Cancer Cytopathol; 2024 Jun; 132(6):340-347. PubMed ID: 38373111
[TBL] [Abstract][Full Text] [Related]
2. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
Zhou H; Mody RR; Luna E; Armylagos D; Xu J; Schwartz MR; Mody DR; Ge Y
Cancer Cytopathol; 2016 May; 124(5):317-23. PubMed ID: 26774025
[TBL] [Abstract][Full Text] [Related]
3. Cytology and curetting diagnosis of endocervical adenocarcinoma.
Bruehl FK; Dyhdalo KS; Hou Y; Clapacs E; Przybycin CG; Reynolds JP
J Am Soc Cytopathol; 2020; 9(6):556-562. PubMed ID: 32624383
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Detection of Cervical Cancer and Precancer Through Use of Imaged Liquid-Based Cytology in Routine Cytology and HPV Cotesting.
Austin RM; Onisko A; Zhao C
Am J Clin Pathol; 2018 Oct; 150(5):385-392. PubMed ID: 30137189
[TBL] [Abstract][Full Text] [Related]
5. Independent validation of distinct clinicopathological features and prognosis among usual-type, mucinous-type and gastric-type endocervical adenocarcinoma categorised by new WHO classification (2020).
Shi H; Shao Y; Zhang H; Ye L; Xu E; Lu B
Pathology; 2022 Aug; 54(5):555-562. PubMed ID: 35346505
[TBL] [Abstract][Full Text] [Related]
6. Clinical performance of the aptima HPV assay in 4196 women with positive high-risk HPV and ASC-US cytology: A large women hospital experience.
Wang T; Pradhan D; Zhang H; Matsko J; Zhao C
Diagn Cytopathol; 2021 Jan; 49(1):5-10. PubMed ID: 32857920
[TBL] [Abstract][Full Text] [Related]
7. Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy.
Cho WK; Kim HS; Park W; Chang CS; Lee YY; Choi CH; Kim TJ; Lee JW; Kim BG
J Gynecol Oncol; 2022 Nov; 33(6):e71. PubMed ID: 36047374
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and carcinogenic risk of high-risk human papillomavirus subtypes in different cervical cytology: a study of 124,251 cases from the largest academic center in China.
Tao X; Zhang H; Wang S; Chen T; Cong Q; Wang L; Zhou X; Zhao C
J Am Soc Cytopathol; 2021; 10(4):391-398. PubMed ID: 33906830
[TBL] [Abstract][Full Text] [Related]
9. The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.
Silver MI; Schiffman M; Fetterman B; Poitras NE; Gage JC; Wentzensen N; Lorey T; Kinney WK; Castle PE
Cancer; 2016 Dec; 122(23):3682-3686. PubMed ID: 27657992
[TBL] [Abstract][Full Text] [Related]
10. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
[TBL] [Abstract][Full Text] [Related]
11. International Endocervical Adenocarcinoma Criteria and Classification (IECC): An Independent Cohort With Clinical and Molecular Findings.
Ren H; Almadani N; Pors J; Leung S; Ho J; Chow C; Ta M; Park KJ; Stolnicu S; Soslow R; Huntsman D; Gilks BC; Hoang L
Int J Gynecol Pathol; 2021 Nov; 40(6):533-540. PubMed ID: 34612210
[TBL] [Abstract][Full Text] [Related]
12. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
[TBL] [Abstract][Full Text] [Related]
13. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
14. The newly proposed International Endocervical Adenocarcinoma Criteria and Classification and its relevance to cervical cytology screening assessed in a prospective 2-year study of 118 cases.
Ondič O; Němcová J; Alaghehbandan R; Černá K; Gomolčáková B; Kinkorová-Luňáčková I; Chytra J; Šidlová H; Hósová M; Bouda J
Cytopathology; 2020 Jul; 31(4):288-291. PubMed ID: 32289186
[TBL] [Abstract][Full Text] [Related]
15. The Updated World Health Organization Classification Better Predicts Survival in Patients With Endocervical Adenocarcinoma (KROG 20-07).
Cho WK; Kim HS; Park W; Kim YS; Kang J; Kim YB; Kim YS; Kim YJ; Kim KR; Kim JH; Kwon SY; Choi JH; Yoon M; Kim NI
Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):154-163. PubMed ID: 36935025
[TBL] [Abstract][Full Text] [Related]
16. Cytology and human papillomavirus screening test results associated with 2827 histopathologic diagnoses of cervical intraepithelial neoplasia 2/3.
Zhao C; Amin M; Weng B; Chen X; Kanbour-Shakir A; Austin RM
Arch Pathol Lab Med; 2013 Jul; 137(7):942-7. PubMed ID: 23050808
[TBL] [Abstract][Full Text] [Related]
17. The clinical performance of primary HPV screening, primary HPV screening plus cytology cotesting, and cytology alone at a tertiary care hospital.
Choi JW; Kim Y; Lee JH; Kim YS
Cancer Cytopathol; 2016 Feb; 124(2):144-52. PubMed ID: 26457676
[TBL] [Abstract][Full Text] [Related]
18. Invasive Squamous Cell Carcinoma of the Cervix: A Review of Morphological Appearances Encountered in Human Papillomavirus-associated and Papillomavirus-independent Tumors and Precursor Lesions.
Stolnicu S; Allison D; Patrichi A; Flynn J; Iasonos A; Soslow RA
Adv Anat Pathol; 2024 Jan; 31(1):1-14. PubMed ID: 37638549
[TBL] [Abstract][Full Text] [Related]
19. Follow-up outcomes of a large cohort of low-risk women with negative imaged liquid-based cytology and negative HPV test results.
Zhao C; Weng B; Li Z; Yang H; Austin RM
Am J Clin Pathol; 2013 Jan; 139(1):32-8. PubMed ID: 23270896
[TBL] [Abstract][Full Text] [Related]
20. Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.
Tao X; Zhang H; Zhang H; Xiao J; Li J; Zhou X; Wang L; Zhao C
Cancer Cytopathol; 2019 Apr; 127(4):258-266. PubMed ID: 30892831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
